Michael D. Hooven, Director at AtriCure, Inc. (ATRC), bought 9,600 shares at $10.50 ($99K) on 2008-06-09, disclosed to the SEC on 2008-06-10.
Open-market purchase of $99k ATRC by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.89 | 1,100 | $11K | 10.9% |
| 2 | $10.32 | 234 | $2K | 2.4% |
| 3 | $10.33 | 2,000 | $21K | 20.8% |
| 4 | $10.40 | 1,900 | $20K | 19.9% |
| 5 | $10.40 | 430 | $4K | 4.5% |
| 6 | $10.48 | 1,336 |
| $14K |
| 14.1% |
| 7 | $10.50 | 2,000 | $21K | 21.1% |
| 8 | $10.50 | 100 | $1K | 1.1% |
| 9 | $10.51 | 100 | $1K | 1.1% |
| 10 | $10.52 | 400 | $4K | 4.2% |
| Total | $10.36 avg | 9,600 | $99K | 100% |
| Filing → |
| ATRC | SELL | 2015-04-01 | $1.5M | — | Filing → |
| ATRC | SELL | 2015-01-02 | $577K | — | Filing → |
| ATRC | BUY | 2012-09-17 | $8K | — | Filing → |